US Patent 11414496 Anti-CD38 binding domains
Patent 11414496 was granted and assigned to Takeda Pharmaceutical Company on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Andrew Walling Drake0
Erin Willert0
Gregory Landes0
Kathleen Ann Elias0
Mary Haak-Frendscho0
Shweta Singh0
Vinay Bhaskar0
Wouter Korver0
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114144960
Date of Patent
August 16, 2022
0Patent Application Number
167511070
Date Filed
January 23, 2020
0Patent Primary Examiner
Edits on 17 Aug, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+270 characters)
US Patent 11414496 Anti-CD38 binding domains
Article
Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding domains, and a method of using the anti-CD38 binding domains or the composition for treating multiple myeloma.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11414496
Date of Patent
August 16, 2022
Patent Application Number
16751107
Date Filed
January 23, 2020
Patent Primary Examiner
Find more entities like US Patent 11414496 Anti-CD38 binding domains
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
